Volume 14, Issue 12 pp. 1687-1714
REVIEW

Metal-based nanoparticles for bone tissue engineering

Reza Eivazzadeh-Keihan

Reza Eivazzadeh-Keihan

Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, Iran

Search for more papers by this author
Ehsan Bahojb Noruzi

Ehsan Bahojb Noruzi

Faculty of Chemistry, Department of Inorganic Chemistry, University of Tabriz, Tabriz, Iran

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Search for more papers by this author
Karim Khanmohammadi Chenab

Karim Khanmohammadi Chenab

Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, Iran

Search for more papers by this author
Amir Jafari

Amir Jafari

Department of Medical Nanotechnology, Faculty of Advanced Technology in Medicine, Iran University of Medical Sciences, Tehran, Iran

Search for more papers by this author
Fateme Radinekiyan

Fateme Radinekiyan

Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, Iran

Search for more papers by this author
Seyed Masoud Hashemi

Seyed Masoud Hashemi

Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, Iran

Search for more papers by this author
Farnoush Ahmadpour

Farnoush Ahmadpour

Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, Iran

Search for more papers by this author
Ali Behboudi

Ali Behboudi

Faculty of Chemical, Petroleum and Gas Engineering, Iran University of Science and Technology, Tehran, Iran

Search for more papers by this author
Jafar Mosafer

Jafar Mosafer

Research Center of Advanced Technologies in Medicine, Torbat Heydariyeh University of Medical Sciences, Torbat Heydariyeh, Iran

Search for more papers by this author
Ahad Mokhtarzadeh

Corresponding Author

Ahad Mokhtarzadeh

Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

Department of Biotechnology, Higher Education Institute of Rab-Rashid, Tabriz, Iran

Correspondence

Ahad Mokhtarzadeh, Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Email: [email protected]

Ali Maleki, Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran.

Email: [email protected]

Michael R Hamblin, Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, 02114, USA.

Email: [email protected]

Search for more papers by this author
Ali Maleki

Corresponding Author

Ali Maleki

Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran, Iran

Correspondence

Ahad Mokhtarzadeh, Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Email: [email protected]

Ali Maleki, Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran.

Email: [email protected]

Michael R Hamblin, Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, 02114, USA.

Email: [email protected]

Search for more papers by this author
Michael R. Hamblin

Corresponding Author

Michael R. Hamblin

Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, Massachusetts, USA

Department of Dermatology, Harvard Medical School, Boston, Massachusetts, USA

Harvard-MIT Division of Health Sciences and Technology, Cambridge, Massachusetts, USA

Correspondence

Ahad Mokhtarzadeh, Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

Email: [email protected]

Ali Maleki, Catalysts and Organic Synthesis Research Laboratory, Department of Chemistry, Iran University of Science and Technology, Tehran 16846-13114, Iran.

Email: [email protected]

Michael R Hamblin, Wellman Center for Photomedicine, Massachusetts General Hospital, Boston, MA, 02114, USA.

Email: [email protected]

Search for more papers by this author
First published: 10 September 2020
Citations: 161

Abstract

Tissue is vital to the organization of multicellular organisms, because it creates the different organs and provides the main scaffold for body shape. The quest for effective methods to allow tissue regeneration and create scaffolds for new tissue growth has intensified in recent years. Tissue engineering has recently used some promising alternatives to existing conventional scaffold materials, many of which have been derived from nanotechnology. One important example of these is metal nanoparticles. The purpose of this review is to cover novel tissue engineering methods, paying special attention to those based on the use of metal-based nanoparticles. The unique physiochemical properties of metal nanoparticles, such as antibacterial effects, shape memory phenomenon, low cytotoxicity, stimulation of the proliferation process, good mechanical and tensile strength, acceptable biocompatibility, significant osteogenic potential, and ability to regulate cell growth pathways, suggest that they can perform as novel types of scaffolds for bone tissue engineering. The basic principles of various nanoparticle-based composites and scaffolds are discussed in this review. The merits and demerits of these particles are critically discussed, and their importance in bone tissue engineering is highlighted.

CONFLICT OF INTEREST

MRH declares the following potential conflicts of interest. Scientific Advisory Boards: Transdermal Cap Inc, Cleveland, OH; BeWell Global Inc, Wan Chai, Hong Kong; Hologenix Inc. Santa Monica, CA; LumiThera Inc, Poulsbo, WA; Vielight, Toronto, Canada; Bright Photomedicine, Sao Paulo, Brazil; Quantum Dynamics LLC, Cambridge, MA; Global Photon Inc, Bee Cave, TX; Medical Coherence, Boston MA; NeuroThera, Newark DE; JOOVV Inc, Minneapolis-St. Paul MN; AIRx Medical, Pleasanton CA; FIR Industries, Inc. Ramsey, NJ; UVLRx Therapeutics, Oldsmar, FL; Ultralux UV Inc, Lansing MI; Illumiheal & Petthera, Shoreline, WA; MB Lasertherapy, Houston, TX; ARRC LED, San Clemente, CA; Varuna Biomedical Corp. Incline Village, NV; Niraxx Light Therapeutics, Inc, Boston, MA. Consulting; Lexington Int, Boca Raton, FL; USHIO Corp, Japan; Merck KGaA, Darmstadt, Germany; Philips Electronics Nederland B.V. Eindhoven, Netherlands; Johnson & Johnson Inc, Philadelphia, PA; Sanofi-Aventis Deutschland GmbH, Frankfurt am Main, Germany. Stockholdings: Global Photon Inc, Bee Cave, TX; Mitonix, Newark, DE.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.